Hjem › Geografisk atrofi
Geografisk atrofi kliniske forsøg rekrutterer i USA
24 studier for Geografisk atrofi rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Dallas, TX8 studier
- Reno, NV8 studier
- Austin, TX7 studier
- Santa Monica, CA7 studier
- Houston, TX6 studier
- Cleveland, OH6 studier
- The Woodlands, TX6 studier
- Naperville, IL6 studier
- Baltimore, MD6 studier
- Spokane, WA5 studier
- Hagerstown, MD5 studier
- San Antonio, TX5 studier
- Erie, PA5 studier
- St. Louis, MO5 studier
- Washington, DC5 studier
- Sacramento, CA5 studier
- Philadelphia, PA4 studier
- Durham, NC4 studier
- Raleigh, NC4 studier
- Lynchburg, VA4 studier
- Fort Worth, TX4 studier
- St. Petersburg, FL4 studier
- Nashville, TN4 studier
- Sarasota, FL3 studier
- Mountain View, CA3 studier
- Los Angeles, CA3 studier
- Pensacola, FL3 studier
- Boston, MA3 studier
- Salt Lake City, UT3 studier
- Huntington Beach, CA3 studier
- Syracuse, NY3 studier
- Eugene, OR3 studier
- Cincinnati, OH3 studier
- Carmel, IN3 studier
- Escondido, CA3 studier
- Concord, CA3 studier
- Abilene, TX3 studier
- McAllen, TX3 studier
- Phoenix, AZ3 studier
- San Francisco, CA3 studier
Efter delstat
- Arizona5 studier
- Californien13 studier
- Colorado4 studier
- Connecticut4 studier
- Florida8 studier
- Georgia4 studier
- Illinois9 studier
- Indiana3 studier
- Maryland7 studier
- Massachusetts7 studier
- Michigan5 studier
- Mississippi3 studier
- Missouri5 studier
- Nevada8 studier
- New Jersey3 studier
- New York4 studier
- North Carolina7 studier
- Ohio7 studier
- Oregon4 studier
- Pennsylvania9 studier
- South Carolina4 studier
- Tennessee4 studier
- Texas15 studier
- Utah4 studier
- Virginia4 studier
- Washington6 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RekruttererFase 2/3
Alder 60 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06635148Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
RekruttererFase 1/2
Alder 55 til 95 · Alle køn · Opdateret 29. sep. 2026 · NCT04339764A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
RekruttererFase 2
Alder 55 til 90 · Alle køn · Opdateret 23. sep. 2026 · NCT06557460A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RekruttererFase 1/2
Alder 55 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07029945A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
RekruttererFase 1/2
Alder 60 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07215234A Study in Adults With Geographic Atrophy
RekruttererFase 2
Alder 60 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
RekruttererFase 2
Alder 50 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RekruttererFase 2
Alder 55 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
RekruttererFase 1
Alder 50 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT03178149A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
RekruttererObservationsstudie
Alder 55 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07144137SGLT2 Inhibitors in Geographic Atrophy
RekruttererFase 2
Alder 50 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT07174687Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Rekrutterer
Alder 60 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT06662162A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
RekruttererFase 2
Alder 55 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT06659549Phase 1 Study of C.001 in Retinal Degeneration
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT07594236Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
RekruttererFase 1
Alder 50 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07230834Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RekruttererFase 1/2
Alder 50 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT07160179Stem Cell Ophthalmology Treatment Study II
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT03011541High Resolution Retinal Imaging
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 7 og opefter · Alle køn · Opdateret 5. maj 2026 · NCT01866371Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
RekruttererObservationsstudie
Alder 55 og opefter · Alle køn · Opdateret 29. apr. 2026 · NCT07556406Progression of Early Atrophic Lesions
RekruttererObservationsstudie
Alder 50 og opefter · Alle køn · Opdateret 11. mar. 2026 · NCT05959005A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD
RekruttererFase 1/2
Alder 50 til 85 · Alle køn · Opdateret 23. jan. 2026 · NCT07158775A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 24. mar. 2025 · NCT06805474Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 3. dec. 2024 · NCT05438732Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.